Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2009
01/27/2009US7482460 Doxepin analogs and methods of use thereof
01/27/2009US7482458 Quinoline derivatives
01/27/2009US7482455 Chemical compounds
01/27/2009US7482449 Combining strong base with phenyl isonicotinamide in aprotic solvents to form solution, then reacting with cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes
01/27/2009US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay
01/27/2009US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide
01/27/2009US7482370 Compounds for the treatment of inflammatory disorders
01/27/2009US7482368 Triamide-substituted heterobicyclic compounds
01/27/2009US7482366 Modulators of LXR
01/27/2009US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
01/27/2009US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
01/27/2009US7482352 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents
01/27/2009US7482350 4,5-disubstituted-2-aryl pyrimidines
01/27/2009US7482349 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5- dihydro-4H-imidazol-4-one
01/27/2009US7482340 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
01/27/2009US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
01/27/2009CA2389280C Triazoles as farnesyl transferase inhibitors
01/27/2009CA2388646C Methods and compositions utilizing quinazolinones
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009012482A2 5-membered heterocyclic amides and related compounds
01/22/2009WO2009011285A1 Heteroarylbenzene compounds
01/22/2009WO2009010846A2 Amorphous form of darifenacin hydrobromide and processes for the preparation thereof
01/22/2009WO2009010521A2 Nir-inert substrates comprising bis-oxodihydroindolylen-benzodifuranones
01/22/2009WO2009010477A1 Piperidine-4-acetic acid derivatives and their use
01/22/2009WO2009010260A2 Condensed anthranilamide insecticides
01/22/2009WO2009010230A2 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
01/22/2009WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same
01/22/2009WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/22/2009US20090023925 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles
01/22/2009US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/22/2009US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms
01/22/2009US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists
01/22/2009US20090023777 Substituted 4-amino-benzylpiperidine compounds
01/22/2009US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists
01/22/2009US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof
01/22/2009US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors
01/22/2009US20090023719 4-(Benzo[d]dioxol-4-ylamino)- or 4-(indazol-4-ylamino)- substituted 2,4-pyrimidinediamine derivatives: N4-(5-chlorobenzo[d][1,3]dioxol-4-yl)-N2-(2,6-dimorpholinopyridin-4-yl)pyrimidine-2,4-diamine; N-(4,6-dimorpholin-4-ylpyrimidin-2-yl)-N'-(1H-indazol-4-yl)-N'-methyl-pyrimidine-2,4-diamine; anticancer
01/22/2009US20090023710 Compound
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/22/2009DE102006014320B4 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase
01/22/2009CA2694475A1 Quinazolinamide derivatives
01/22/2009CA2693880A1 Pyrimidine derivatives 934
01/22/2009CA2692896A1 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
01/22/2009CA2691507A1 5-membered heterocyclic amides and related compounds
01/22/2009CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors
01/21/2009EP2016088A2 Process for preparing disulphides and thiosulphinates and compounds prepared
01/21/2009EP2016074A1 Inhibitors of c-fms kinase
01/21/2009EP2016070A1 Inhibitors of c-fms kinase
01/21/2009EP2016064A2 Methods for the preparation of pyrazole-containing compounds
01/21/2009EP2016060A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
01/21/2009EP2016057A1 C-fms kinase inhibitors
01/21/2009EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
01/21/2009EP1674460B1 Chromene compound
01/21/2009EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
01/21/2009EP1626964B1 New benzimidazole derivatives
01/21/2009EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases
01/21/2009EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
01/21/2009EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof
01/21/2009EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
01/21/2009EP1444211B1 Quinazoline derivatives as antitumor agents
01/21/2009EP1339690B1 N-type calcium channel antagonists for the treatment of pain
01/21/2009CN101351524A Use of rylene derivatives as photosensitizers in solar cells
01/21/2009CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth
01/21/2009CN100453534C Substituted dihydropyrimidinone preparation using polyaniline salt catalyst
01/20/2009US7479562 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester
01/20/2009US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
01/20/2009US7479504 Edg receptor agonists
01/20/2009US7479501 Heteroaryl-cyclic acetals
01/20/2009US7479495 N-heterocyclic inhibitors of TNF-α expression
01/20/2009US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands
01/20/2009US7479471 Applying to plants, seeds
01/20/2009CA2528493C Medicinal composition containing triazole compound
01/20/2009CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
01/20/2009CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
01/20/2009CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same
01/20/2009CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
01/20/2009CA2339961C Isoquinoline derivatives with angiogenesis inhibiting activity
01/20/2009CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
01/20/2009CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
01/20/2009CA2220759C 1,4-benzodioxin derivatives
01/15/2009WO2009009059A1 Spiro compounds as antagonists of tgf-beta
01/15/2009WO2009007987A1 An improved process for the preparation of alfuzosin and its novel polymorph
01/15/2009WO2009007399A1 New compounds as hsp90 inhibitors
01/15/2009WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use
01/15/2009WO2008128622A3 Pyridine compounds for liquid-crystalline mixtures
01/15/2009US20090018346 Amorphous Form Of Darifenacin Hydrobromide And Processes For The Preparation Thereof
01/15/2009US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use
01/15/2009US20090018177 Propane-1,3-Dione Derivative or Salt Thereof
01/15/2009US20090018157 Chemical compounds
01/15/2009US20090018145 Compositions and their use as anti-tumor agents
01/15/2009US20090018133 Novel Adamantane Derivatives
01/15/2009US20090018113 Novel Cylopenta[B]Benzofuran Derivatives and the Utilization Thereof
01/15/2009US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/15/2009US20090017546 Fluorescent isotope tags and their method of use
01/14/2009EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor
01/14/2009EP2014656A2 New heteocyclic h3 antagonists